Thiamine and benfotiamine improve cognition and ameliorate GSK-3β-associated stress-induced behaviours in mice.
Thiamine (vitamin B1) deficiency in the brain has been implicated in the development of dementia and symptoms of depression. Indirect evidence suggests that thiamine may contribute to these pathologies by controlling the activities of glycogen synthase kinase (GSK)-3β. While decreased G...
Main Authors: | Markova, N, Bazhenova, N, Anthony, D, Vignisse, J, Svistunov, A, Lesch, K, Bettendorff, L, Strekalova, T |
---|---|
Formato: | Journal article |
Idioma: | English |
Publicado em: |
Elsevier
2016
|
Registos relacionados
-
Thiamine and benfotiamine prevent stress-induced suppression of hippocampal neurogenesis in mice exposed to predation without affecting brain thiamine diphosphate levels
Por: Vignisse, J, et al.
Publicado em: (2017) -
Thiamine and benfotiamine: Focus on their therapeutic potential
Por: Iva Bozic, et al.
Publicado em: (2023-11-01) -
Chemoreactomic analysis of thiamine disulfide, thiamine hydrochloride, and benfotiamine molecules
Por: O. A. Gromova, et al.
Publicado em: (2017-07-01) -
Benfotiamine Supplementation Increases Thiamine in Muscle of Endurance-Trained Mice and Affects the Energy Metabolism
Por: Álisson C. Gonçalves, et al.
Publicado em: (2024-01-01) -
Prostatic acid phosphatase is required for the antinociceptive effects of thiamine and benfotiamine.
Por: Julie K Hurt, et al.
Publicado em: (2012-01-01)